Tradestie Institutional Equity Comparison Engine
MXCT vs ISPC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MXCT Overall Edge
MXCT Captures Institutional Edge (3โ0 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus ISPC at N/M Forward P/E and -1455.3% operating margin (+128.9% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ISPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MXCT N/M vs ISPC N/M Fwd P/E
Growth & Margin Winner
MXCT
Op Margin -85.5% vs -1455.3% ยท YoY +48.7% vs +128.9%
Momentum & Technical Winner
MXCT
1Y -19.4% vs -10.0% ยท 52W Pos 63% vs 5%
Options & Structure Winner
MXCT
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MXCT
NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap
$132.2M
1M Return
-4.2%
1Y Return
-19.41%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 46.0
Fund 52.0
Flow 62.0
Mom 50.0
ISPC
NASDAQ
iSpecimen Inc. Common Stock
Services-Commercial Physical & Biological Research
$0.46
-13.58% 1D
Market Cap
$3.1M
1M Return
-45.2%
1Y Return
-10.0%
Forward P/E
N/M
Unified AI Score
41.6 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MXCT -19.41%
ISPC -10.0%
Spread: +9.41 pp (ISPC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MXCT Revenue | ISPC Revenue | MXCT Op. Margin | ISPC Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | N/A | -93.7% | N/A | MXCT |
| FY2020 | $20M | $10M | -71.6% | -29.4% | ISPC |
| FY2021 | $20M | $10M | -84.3% | -53.2% | ISPC |
| FY2022 | $30M | $10M | -95.2% | -97.9% | MXCT |
| FY2023 | $20M | $10M | -247.7% | -112.5% | ISPC |
| FY2024 | $20M | $10M | -230.5% | -137.0% | ISPC |
| FY2025 | $20M | $0M | -247.6% | -465.4% | MXCT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MXCT | ISPC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $3.1M | Larger Scale | MXCT |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +48.7% | +128.9% | Higher Growth | ISPC |
| Operating Margin (TTM) Profitability | -85.5% | -1455.3% | Higher Margin | MXCT |
| Net Profit Margin Profitability | -81.4% | 0.0% | Higher Margin | ISPC |
| Return on Equity (ROE) Capital Efficiency | -16.9% | -303.9% | Higher ROE | MXCT |
| 52-Week Range Position Momentum | 63% ($1โ$2) | 5% ($0โ$7) | Stronger Trend | MXCT |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 96% Vol | -10.07ฮฒ ยท 74% Vol | Lower Realized Risk | ISPC |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 41.6 / 100 (SELL) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MXCT vs ISPC Buy Guide
MXCT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ISPC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MXCT nor ISPC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.